|
Univariate analysis
|
Multivariate analysis
|
---|
|
p value
|
Hazard ratio
|
95.0 % CI
|
p value
|
Hazard ratio
|
95.0 % CI
|
---|
| | |
Lower
|
Upper
| | |
Lower
|
Upper
|
---|
Age (≤72 years old vs >72)
|
0.014
|
4.136
|
1.332
|
12.843
|
0.006
|
5.811
|
1.656
|
20.386
|
PSA (>247 ng/mL vs ≤247 ng/mL)
|
0.981
|
1.012
|
0.379
|
2.703
|
0.407
|
0.621
|
0.201
|
1.914
|
Gleason score (10–8 vs ≤7)
|
0.983
|
1.017
|
0.228
|
4.543
|
0.617
|
1.640
|
0.236
|
11.403
|
T stage (4 vs ≤3)
|
0.239
|
1.908
|
0.651
|
5.588
|
0.137
|
2.576
|
0.741
|
8.953
|
N stage (1 vs 0)
|
0.723
|
1.198
|
0.441
|
3.255
|
0.251
|
2.035
|
0.605
|
6.843
|
M stage (1c vs 1b)
|
0.744
|
0.780
|
0.176
|
3.462
|
0.467
|
0.524
|
0.092
|
2.990
|
BSI (>1.9 % vs ≤1.9 %)
|
0.049
|
2.921
|
1.006
|
8.483
|
0.023
|
4.676
|
1.238
|
17.661
|
-
PSA prostate-specific antigen, BSI bone scan index